Indivior | INDV - Ebitda





Ebitda تغيير تاريخ
AstraZeneca USD 5.67B 1.29B 2026-03
Cassava Sciences USD -11.73M 33.44M 2025-09
GlaxoSmithKline GBP 3.51B 734M 2026-06
Glaxosmithkline GBP 2.77B 1.98B 2026-03
Hikma Pharmaceutical USD 369M 84M 2024-12
Roche Holding CHF 13.43B 744M 2026-06
West Pharmaceutical Services USD 243.6M 17.4M 2026-06